The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ABIOMED INC COM 003654100 79,191 3,150,000 SH   SOLE   3,150,000 0 0
ACURA PHARMACEUTICALS INC COM NEW 00509L703 10,662 10,284,886 SH   SOLE   10,284,886 0 0
CORIUM INTL INC COM 21887L107 72,675 9,353,304 SH   SOLE   9,353,304 0 0
CURIS INC COM 231269101 435 233,797 SH   SOLE   233,797 0 0
ECHO THERAPEUTICS INC COM NEW 27876L206 28 12,319 SH   SOLE   12,319 0 0
ENDOLOGIX INC COM 29266S106 60,066 2,814,936 SH   SOLE   2,814,936 0 0
HORIZON PHARMA INC COM 44047T109 88,982 5,815,940 SH   SOLE   5,815,940 0 0
MEDICINOVA INC COM NEW 58468P206 2,376 1,170,370 SH   SOLE   1,170,370 0 0
PALATIN TECHNOLOGIES INC COM PAR $ .01 696077403 24 23,928 SH   SOLE   23,928 0 0
REVANCE THERAPEUTICS INC COM 761330109 156,130 4,592,047 SH   SOLE   4,592,047 0 0
ZIOPHARM ONCOLOGY INC COM 98973P101 10,257 2,764,908 SH   SOLE   2,764,908 0 0